MODALITY PARTNERSHIP (HULL) — All Prescriptions & Medications — Page 16
Practice Code: B81048 | HULL, HU5 2NT
Showing results 751-800 of 944
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 25 | 1,960 | £1.4K | +88.3% ▲ | |
| 25 | 1,340 | £4.6K | +112.8% ▲ | |
| 25 | 1,040 | £4.9K | +201.1% ▲ | |
| Promethazine teoclate | 24 | 784 | £114 | +139.7% ▲ |
| Phenytoin | 24 | 20.4K | £297 | +118.6% ▲ |
| 24 | 2,130 | £3.2K | +145.3% ▲ | |
| 24 | 460 | £659 | +148.4% ▲ | |
| 24 | 1,030 | £7.0K | +243.7% ▲ | |
| Prednisolone sodium metasulphobenzoate | 23 | 27 | £9.0K | +482.4% ▲ |
| Magnesium aspartate | 23 | 973 | £856 | +51.9% ▲ |
| Tube feed 1 kcal/ml peptide based (0914032) | 23 | 791.0K | £18.6K | +157.8% ▲ |
| Atropine sulfate | 23 | 900 | £738 | +80.5% ▲ |
| Ketorolac trometamol | 23 | 160 | £137 | +147.9% ▲ |
| Tirbanibulin | 23 | 115 | £1.3K | +266.6% ▲ |
| 23 | 1,490 | £4.7K | +101.9% ▲ | |
| 23 | 780 | £667 | +248.8% ▲ | |
| Vortioxetine | 22 | 840 | £790 | -68.3% ▼ |
| Ethosuximide | 22 | 5,092 | £10.4K | +49.1% ▲ |
| Linagliptin/metformin | 22 | 1,232 | £695 | -34.7% ▼ |
| Sirolimus | 22 | 660 | £1.8K | +86.0% ▲ |
| Other phosphate supplement preparations | 22 | 2,000 | £374 | +260.5% ▲ |
| Calcitriol | 22 | 1,130 | £328 | +41.0% ▲ |
| 22 | 341 | £311 | -40.6% ▼ | |
| 22 | 1,740 | £883 | -40.7% ▼ | |
| 22 | 970 | £465 | +174.4% ▲ | |
| 22 | 660 | £1.8K | +60.9% ▲ | |
| Trandolapril | 21 | 1,148 | £130 | +101.9% ▲ |
| Bempedoic acid/Ezetimibe | 21 | 588 | £1.1K | -65.6% ▼ |
| Tapentadol | 21 | 1,092 | £1.6K | -49.0% ▼ |
| Cefradine | 21 | 880 | £605 | +121.8% ▲ |
| Dapoxetine hydrochloride | 21 | 117 | £552 | +357.4% ▲ |
| Lanthanum carbonate | 21 | 1,630 | £3.2K | +156.0% ▲ |
| Loteprednol etabonate | 21 | 130 | £136 | +127.1% ▲ |
| Hydrocortisone butyrate | 21 | 2,100 | £102 | +217.2% ▲ |
| 21 | 52 | £1.3K | +163.7% ▲ | |
| 21 | 1,110 | £2.7K | +37.9% ▲ | |
| Dicycloverine hydrochloride | 20 | 1,932 | £2.5K | +68.9% ▲ |
| Ciprofibrate | 20 | 756 | £2.0K | +49.8% ▲ |
| Buprenorph hydrochloride/naloxone hydrochloride | 20 | 298 | £544 | -37.6% ▼ |
| Enteral nutrition | 20 | 351.0K | £9.8K | +155.9% ▲ |
| RtS extensively hydrolysed formula, high energy (0913103) | 20 | 425.2K | £10.9K | +249.4% ▲ |
| Fusidic acid | 20 | 105 | £396 | +93.6% ▲ |
| Hyetellose | 20 | 1,420 | £630 | +148.4% ▲ |
| 20 | 54 | £3.5K | +120.4% ▲ | |
| Exenatide | 19 | 71 | £2.0K | +8.4% ▲ |
| Tube feed 1 kcal/ml with fibre (0914011) | 19 | 532.0K | £8.1K | +84.1% ▲ |
| 19 | 1,560 | £4.4K | +28.4% ▲ | |
| 19 | 930 | £1.4K | +16.4% ▲ | |
| Fluvoxamine maleate | 18 | 759 | £322 | +48.1% ▲ |
| Saxagliptin/metformin | 18 | 1,288 | £691 | +7.5% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.